China SXT Pharmaceuticals, Inc.
Cash Flow Statement
| Line Item | FY2018 | FY2017 |
|---|---|---|
| Operating Activities | ||
| Net Income | $1.2M | $1.2M |
| Depreciation & Amortization | $129.4K | — |
| Depreciation | $123.3K | $94.4K |
| Amortization | $6.2K | $4.8K |
| Stock-Based Compensation | — | — |
| Net Cash from Operating Activities | $1.9M | $293.0K |
| Investing Activities | ||
| Capital Expenditures | $436.0K | $179.2K |
| Business Acquisitions | — | — |
| Net Cash from Investing Activities | $-1.1M | $-186.3K |
| Financing Activities | ||
| Dividends Paid | — | — |
| Stock Repurchases | — | — |
| Net Cash from Financing Activities | $-314.2K | $-50.6K |
| Net Change in Cash | $592.2K | $54.1K |
| Free Cash Flow | $1.5M | $113.9K |